Zeria Pharmaceutical Co., Ltd. (4559)
Market Closed
10 Aug, 06:00
JPX JPX Primary 
TWSE ¥
2,057. 00
+22
+1.0811%
¥
90.54B Market Cap
- P/E Ratio
50% Div Yield
97,200 Volume
- Eps
¥ 2,035
Previous Close Want to track 4559 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Zeria Pharmaceutical Co., Ltd. (4559) Statistics
Valuation metrics
Market Cap 90.54B
Enterprise value 101.05B
Trailing P/E (ttm) 10.61
Forward P/E 11.4
PEG ratio -0.71
Price/Sales (ttm) 1.01
Price/Book (mrq) 0.83
Enterprise Value/Revenue 1.13
Enterprise Value/EBITDA 5.12
Overview
Shares outstanding 44.08M
Float 33.38M
Shares short -
% Held by insiders 0.3%
% Held by institutions 0.19%
Average volume (10 days) 124.38K
Average volume (90 days) 90.94K
Price summary
52-Week low 1,878
52-Week high 2,434
Beta 0.06
50-Day moving average 2,066.54
200-Day moving average 2,163.34
Dividends and splits
Forward annual dividend rate 50
Forward annual dividend yield 0.021%
Trailing annual dividend rate 49
Trailing annual dividend yield 0.0241%
5-Year annual dividend yield 1.92%
Payout ratio 0.26
Dividend Date 1 Dec 2025
Ex-Dividend Date 29 Sep 2025
Last split factor 1:1
Last split Date 26 Sep 2013
Financials
Fiscal year
Fiscal year ends 31 Mar 2026
Most recent quarter (mrq) 30 Jun 2025
Profitability
Profit margin 0.09%
Operating margin 0.14%
Operational effectiveness
Return on assets 0.05%
Return on equity 0.09%
Income Statement
Revenue (ttm) 89.16B
Revenue per share (ttm) 2,022.72
Quarterly revenue growth (yoy) 0.11%
Gross profit (ttm) 65.18B
EBITDA 20.85B
Net income to common (ttm) 8.45B
Diluted EPS (ttm) 191.8
Quarterly earnings growth (yoy) 0.7%
Balance Sheet
Total cash (mrq) 27.76B
Total cash per share (mrq) 629.78
Total debt (mrq) 39.1B
Total Debt/Equity (mrq) 0.36
Current ratio (mrq) 1.48%
Book value per share (mrq) 2,463.87
Cash Flow
Cash flow statement 9.96B
Levered free cash flow (LFCF) 4.65B
